Source: International Congress 2015 – New insights into IIPs
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Mary McElroy (Edinburgh, United Kingdom), Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber. Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging. Eur Respir J 2015; 46: Suppl. 59, 4858

Member's Comments

No comment yet.

Related content which might interest you: Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients Source: International Congress 2014 – ILDs 2 Year: 2014 IPFdatabase – A new tool for a correct application of idiopathic pulmonary fibrosis guidelines Source: International Congress 2014 – ILDs 2 Year: 2014 Shear Wave imaging (SVI): A potential tool for analyzing early fibrotic changes in the subpleural space Source: Annual Congress 2013 –The different modalities for current imaging and for future issues Year: 2013 Fibulin-1 is a novel biomarker of disease severity in pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations Source: International Congress 2015 – New insights into IIPs Year: 2015 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Changes in the small airways in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Imaging of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Comet tail artifact: A transthoracic chest ultrasound sign useful in assessment of interstitial lung diseases Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 IGFBP-2 a new interesting target in IPF Source: International Congress 2016 – ILD pathogenesis Year: 2016 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Surfactant protein B proforms as potential new biomarkers for idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing Source: International Congress 2015 – New insights into IIPs Year: 2015 Prognostic value of dual-time-point 18F-FDG PET in fibrotic idiopathic interstitial pneumonia Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014